Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?

Ashton A. Connor, Steven Gallinger

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Introduction: Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate of all epithelial malignancies and a paradoxically rising incidence rate. Clinical translation of next generation sequencing (NGS) of tumour and germline samples may ameliorate outcomes by identifying prognostic and predictive genomic and transcriptomic features in appreciable fractions of patients, facilitating enrolment in biomarker-matched trials. Areas covered: The literature on precision oncology is reviewed. It is found that outcomes may be improved across various malignancies, and it is suggested that current issues of adequate tissue acquisition, turnaround times, analytic expertise and clinical trial accessibility may lessen as experience accrues. Also reviewed are PDAC genomic and transcriptomic NGS studies, emphasizing discoveries of promising biomarkers, though these require validation, and the fraction of patients that will benefit from these outside of the research setting is currently unknown. Expert commentary: Clinical use of NGS with PDAC should be used in investigational contexts in centers with multidisciplinary expertise in cancer sequencing and pancreatic cancer management. Biomarker directed studies will improve our understanding of actionable genomic variation in PDAC, and improve outcomes for this challenging disease.

Original languageEnglish (US)
Pages (from-to)683-694
Number of pages12
JournalExpert Review of Gastroenterology and Hepatology
Issue number7
StatePublished - Jul 3 2017


  • Pancreatic ductal adenocarcinoma
  • clinical translation
  • genomics
  • precision oncology
  • transcriptomics

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?'. Together they form a unique fingerprint.

Cite this